| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.23 | 6e-06 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.19 | 0.0002 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.19 | 0.0006 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.18 | 0.0009 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |